News Charles River Laboratories International, Inc. Xetra

Stocks

RV6

US1598641074

Biotechnology & Medical Research

All News

Mentions Relevance

07-09	Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
07-07	Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
07-04	Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
07-02	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
07-01	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT
06-18	Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise	BU
06-18	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT
06-18	Charles River Laboratories Shares Rise After Morgan Stanley Upgrade	MT
06-17	Morgan Stanley Upgrades Charles River Laboratories International to Overweight From Equal Weight, Adjusts PT to $220 From $185	MT
06-05	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
06-03	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM
06-03	Charles River Laboratories International, Inc. Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 10:00 AM
06-01	Charles River Laboratories to Present at William Blair and Jefferies Conferences	BU
05-13	Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing	MT
05-13	Charles River Laboratories and Medipost sign non-exclusive MoU to advance GMP testing solutions	RE
05-13	Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions	BU
05-12	Charles River Laboratories International, Inc. Approves Ratification of PricewaterhouseCoopers LLP as Independent Auditors	CI
05-12	Charles River Laboratories International, Inc. Announces Board Elections	CI
05-11	Charles River Laboratories International, Inc. Accelerates Digital Pathology with Ai-Powered End-To-End Workflow	CI
05-11	Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow	BU
05-08	Charles River Laboratories International, Inc. Seeks M&A Opportunities	CI
05-08	Charles River Laboratories International : Quarterly Report for Quarter Ending March 28, 2026 (Form 10-Q)	PU
05-08	Tranche Update on Charles River Laboratories International, Inc.'s Equity Buyback Plan announced on November 5, 2025.	CI
05-07	Charles River Laboratories International, Inc., Q1 2026 Earnings Call, May 07, 2026
05-07	Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 28, 2026	CI